Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Long-Term Investments (2023 - 2026)

MDxHealth has reported Long-Term Investments over the past 4 years, most recently at $1.6 million for Q1 2026.

  • For Q1 2026, Long-Term Investments changed N/A year-over-year to $1.6 million; the TTM value through Mar 2026 reached $1.6 million, changed N/A, while the annual FY2025 figure was $1.5 million, 59.83% up from the prior year.
  • Long-Term Investments was $1.6 million for Q1 2026 at MDxHealth, up from $1.5 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $1.6 million in Q1 2026 and bottomed at $763000.0 in Q4 2023.
  • The 4-year median for Long-Term Investments is $1.2 million (2024), against an average of $1.2 million.
  • Year-over-year, Long-Term Investments grew 22.67% in 2024 and then skyrocketed 59.83% in 2025.
  • Over 4 years, Long-Term Investments stood at $763000.0 in 2023, then grew by 22.67% to $936000.0 in 2024, then surged by 59.83% to $1.5 million in 2025, then increased by 10.23% to $1.6 million in 2026.
  • The last three reported values for Long-Term Investments were $1.6 million (Q1 2026), $1.5 million (Q4 2025), and $936000.0 (Q4 2024) per Business Quant data.